MSB 2.12% 92.5¢ mesoblast limited

Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L, page-828

  1. 104 Posts.
    lightbulb Created with Sketch. 11
    Fda have been fighting msb all the way but the swamp drainer won't let em win . Big pharma will lose billions and they ain't happy.msb has the answer to a huge range of diseases. I watched a doco on pancreatic cancer last night a mate of mine had this an it killed him quick.in the doco a cytokine storm was said to be a major problem meso blast addresses this problem and many others . President Trump said 6 months ago a new treatment to treat thosands of diseases was on the way and has cut big pharma ability to charge huge prices by up to 80 percent. I for one won't be surprised when msb proves to have the cures the president mentioned
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
92.5¢
Change
-0.020(2.12%)
Mkt cap ! $1.056B
Open High Low Value Volume
93.0¢ 93.5¢ 92.0¢ $2.103M 2.270M

Buyers (Bids)

No. Vol. Price($)
11 106422 92.5¢
 

Sellers (Offers)

Price($) Vol. No.
93.0¢ 59027 3
View Market Depth
Last trade - 16.10pm 09/09/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.